New Technology Improves IVF Implantation Rates, Expanding Access
Innovative IVF techniques are emerging to improve implantation predictions through non-invasive, AI-driven metabolomics assays.
Category: Womens Health
Womens Health
Latest
Womens Health
Latest
NIH Study Links Abnormal Prenatal DNA Tests to Cancer Detection
NIH researchers found undetected cancers in nearly half of pregnant people with abnormal prenatal cfDNA test results.
Womens Health
Latest
Blood Test Predicts 30-Year Cardiovascular Disease Risks for Women
A study found that elevated blood levels of LDL cholesterol, Lp(a), and CRP significantly increase long-term cardiovascular risk.
Better Congenital CMV Screening Needs More Awareness, Legislative Action
Recent advancements in congenital CMV (cCMV) screening underscore the need for enhanced awareness and legislative action.
Read More
New Test Rapidly Diagnoses Toxoplasma Infection
The test monitors pregnant women for Toxoplasma gondii infections, and detects infections within 30 minutes from a finger-prick.
Read More
Accounting for Self-Reported Race in Prenatal Screening Is Vital
Labs should consider self-reported race when screening for open neural tube defects to improve prenatal care equity for Black individuals.
Read More
First Trimester Screening Test Assesses Preeclampsia Risk
Labcorp has introduced a first trimester preeclampsia screening test to assess preeclampsia risk between 11- and 14-weeks’ gestation.
Read More
PinkDX to Develop Diagnostics that Address Women’s Unmet Medical Needs
PinkDx, an early-stage company focused on positively impacting the health of women, launched with $40 million in Series A financing.Â
Read More
How New Machine Learning Models Can Help Diagnose Women’s Heart Disease
Researchers in the U.S. and the Netherlands have now used a large dataset to build more accurate cardiovascular risk models.
Read More
Making the Case for New Biomarker-based Assays
Clinicians can now use two new biomarker-based assays in combination to determine which patients are at higher risk for poor outcomes.
Read More
Agilent’s Postnatal Assay Gets European IVDR Class C Certification
Agilent Technologies announced that its GenetiSure Dx Postnatal Assay received European IVDR Class C Certification.
Read More
Siemens’ New Reproductive Assay to Help Guide In Vitro Fertilization
The AMH Assay can support a lab’s reproductive endocrinology test menu as it aids a physician’s assessment of initiating IVF with a patient.
Read More
QuidelOrtho’s Triage Placental Growth Factor Test Approved for Labs Canada
The test is for use with the Triage MeterPro for the quantitative determination of placental growth factor in maternal plasma specimens.Â
Read More
New Test Could Identify Aggressive Ovarian Cancers Early
A new algorithm may help identify high-risk precancerous lesions on the fallopian tubes thought to lead to a common form of ovarian cancer
Read More
How Menstrual Blood Is Being Transformed Into a Diagnostic Tool
CLP’s Chris Wolski interviews Sara Naseri, MD, co-founder and CEO of Qvin, about a menstrual pad that collects blood for diagnostic purposes.
Read More
New Primer Sets for Bacterial and Fungal Digital PCR and Real-time PCR Assays
Fort Worth Diagnostics utilizes digital PCR to establish the assays and ensure reproducibility while manufacturing high-quality materials.
Read More
Labcorp Launches Blood Test for Risk Assessment and Clinical Management of Preeclampsia
The test measures angiogenic biomarkers associated with preeclampsia, serum soluble fms-like tyrosine kinase 1 and placental growth factor.
Read More
Researchers Leverage AI for Early Diagnostic Test for Ovarian Cancer
Scientists combined machine learning with info on blood metabolites to develop a new test able to detect ovarian cancer with 93% accuracy.
Read More